2 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
Follow TH 302: new trials by email Literature Review of TH 302 trials Research Report on TH 302
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Japanese Trial of TH-302 in Subjects With Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma TH-302, Doxorubicin - Soft Tissue Sarcoma | Phase 2 | Terminated | Merck KGaA, Darmstadt, Germany | 6 | 2014-12-10 | 2018-12-14 |
| A Phase 2 Biomarker - Enriched Study of TH-302 in Subjects With Advanced Melanoma TH-302 - Metastatic Melanoma | Phase 2 | Terminated | ImmunoGenesis | 11 | 2013-05-01 | 2025-05-11 |
Melanoma (1) · Neoplasm Metastasis (1) · Sarcoma (1)
ImmunoGenesis (1) · Merck KGaA, Darmstadt, Germany (1)
Canada (1) · Japan (1) · United States (1)